BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 1906990)

  • 1. Formation of beta-amyloid protein deposits in brains of transgenic mice.
    Quon D; Wang Y; Catalano R; Scardina JM; Murakami K; Cordell B
    Nature; 1991 Jul; 352(6332):239-41. PubMed ID: 1906990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein.
    Games D; Adams D; Alessandrini R; Barbour R; Berthelette P; Blackwell C; Carr T; Clemens J; Donaldson T; Gillespie F
    Nature; 1995 Feb; 373(6514):523-7. PubMed ID: 7845465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease.
    Tanzi RE; McClatchey AI; Lamperti ED; Villa-Komaroff L; Gusella JF; Neve RL
    Nature; 1988 Feb; 331(6156):528-30. PubMed ID: 2893290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
    van Groen T; Kiliaan AJ; Kadish I
    Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of amyloid beta-protein gene in Alzheimer's disease].
    Tanaka S; Nakamura S; Ueda K
    Rinsho Byori; 1990 May; 38(5):489-93. PubMed ID: 2116540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and expression of multiple forms of beta amyloid protein precursor cDNAs.
    Donnelly RJ; Jacobsen JS; Rasool CG; Blume AJ; Vitek MP
    Prog Clin Biol Res; 1989; 317():925-37. PubMed ID: 2481324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APP gene family: unique age-associated changes in splicing of Alzheimer's betaA4-amyloid protein precursor.
    Sandbrink R; Masters CL; Beyreuther K
    Neurobiol Dis; 1994 Nov; 1(1-2):13-24. PubMed ID: 9216982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation of amyloid-like fibrils in COS cells overexpressing part of the Alzheimer amyloid protein precursor.
    Maruyama K; Terakado K; Usami M; Yoshikawa K
    Nature; 1990 Oct; 347(6293):566-9. PubMed ID: 1977086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The secreted form of the Alzheimer's amyloid precursor protein with the Kunitz domain is protease nexin-II.
    Oltersdorf T; Fritz LC; Schenk DB; Lieberburg I; Johnson-Wood KL; Beattie EC; Ward PJ; Blacher RW; Dovey HF; Sinha S
    Nature; 1989 Sep; 341(6238):144-7. PubMed ID: 2506449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic background regulates beta-amyloid precursor protein processing and beta-amyloid deposition in the mouse.
    Lehman EJ; Kulnane LS; Gao Y; Petriello MC; Pimpis KM; Younkin L; Dolios G; Wang R; Younkin SG; Lamb BT
    Hum Mol Genet; 2003 Nov; 12(22):2949-56. PubMed ID: 14506131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-amyloid precursor protein transgenic mice that harbor diffuse A beta deposits but do not form plaques show increased ischemic vulnerability: role of inflammation.
    Koistinaho M; Kettunen MI; Goldsteins G; Keinänen R; Salminen A; Ort M; Bures J; Liu D; Kauppinen RA; Higgins LS; Koistinaho J
    Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1610-5. PubMed ID: 11818564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraneuronal amyloid beta and reduced brain volume in a novel APP T714I mouse model for Alzheimer's disease.
    Van Broeck B; Vanhoutte G; Pirici D; Van Dam D; Wils H; Cuijt I; Vennekens K; Zabielski M; Michalik A; Theuns J; De Deyn PP; Van der Linden A; Van Broeckhoven C; Kumar-Singh S
    Neurobiol Aging; 2008 Feb; 29(2):241-52. PubMed ID: 17112635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The beta amyloid protein precursor: mRNAs, membrane-associated forms, and soluble derivatives.
    Palmert MR; Podlisny MB; Golde TE; Cohen ML; Kovacs DM; Tanzi RE; Gusella JF; Whitehouse PJ; Witker DS; Oltersdorf T
    Prog Clin Biol Res; 1989; 317():971-84. PubMed ID: 2513588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropathology of mice carrying mutant APP(swe) and/or PS1(M146L) transgenes: alterations in the p75(NTR) cholinergic basal forebrain septohippocampal pathway.
    Jaffar S; Counts SE; Ma SY; Dadko E; Gordon MN; Morgan D; Mufson EJ
    Exp Neurol; 2001 Aug; 170(2):227-43. PubMed ID: 11476589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presenilin 1 regulates the processing of beta-amyloid precursor protein C-terminal fragments and the generation of amyloid beta-protein in endoplasmic reticulum and Golgi.
    Xia W; Zhang J; Ostaszewski BL; Kimberly WT; Seubert P; Koo EH; Shen J; Selkoe DJ
    Biochemistry; 1998 Nov; 37(47):16465-71. PubMed ID: 9843412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implications for Alzheimer's disease.
    Mohmmad Abdul H; Sultana R; Keller JN; St Clair DK; Markesbery WR; Butterfield DA
    J Neurochem; 2006 Mar; 96(5):1322-35. PubMed ID: 16478525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central cholinergic functions in human amyloid precursor protein knock-in/presenilin-1 transgenic mice.
    Hartmann J; Erb C; Ebert U; Baumann KH; Popp A; König G; Klein J
    Neuroscience; 2004; 125(4):1009-17. PubMed ID: 15120860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of APP pathway mRNAs and proteins in Alzheimer's disease.
    Matsui T; Ingelsson M; Fukumoto H; Ramasamy K; Kowa H; Frosch MP; Irizarry MC; Hyman BT
    Brain Res; 2007 Aug; 1161():116-23. PubMed ID: 17586478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frame-shifted amyloid precursor protein found in Alzheimer's disease and Down's syndrome increases levels of secreted amyloid beta40.
    van Dijk R; Fischer DF; Sluijs JA; Sonnemans MA; Hobo B; Mercken L; Mann DM; Hol EM; van Leeuwen FW
    J Neurochem; 2004 Aug; 90(3):712-23. PubMed ID: 15255950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of transgenic APP mRNA is the key determinant for beta-amyloid deposition in PS2APP transgenic mice.
    Ozmen L; Albientz A; Czech C; Jacobsen H
    Neurodegener Dis; 2009; 6(1-2):29-36. PubMed ID: 19066434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.